跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 92,373 条关于
“pH-D Feminine Health”
全部
92,373
临床试验
69,637
药物
2,131
机构
4,489
资讯
16,116
去年
pH-D Feminine Health Initiates First FDA-Cleared Phase 3 Trial for Boric Acid Suppositories in Yeast Infections
去年
Maternal Vitamin D Levels During Early Pregnancy Significantly Impact Infant Health Outcomes
去年
Merck Animal Health Commits $895 Million to Expand Kansas Manufacturing and R&D Facilities
去年
Current Treatment Protocols for Ph+ ALL Treatment
去年
Advances in TKIs and Immunotherapy Shift Treatment Paradigm in Ph-Positive ALL
去年
Ponatinib Plus Chemotherapy Shows Promise in Philadelphia Chromosome-Positive ALL
去年
FDA Approves Asciminib (Scemblix) for Newly Diagnosed Philadelphia Chromosome-Positive CML
去年
FDA Approves Nilotinib (Danziten) with No Mealtime Restrictions for Ph+ CML
去年
FDA Approves Asciminib for Newly Diagnosed Philadelphia Chromosome-Positive CML
去年
FDA Grants Breakthrough Therapy Designation to Olverembatinib for Ph+ Leukemia Treatment
第 1 页,共 1612 页
上一页
下一页